Waterfield Advisors Equities Head Suggests Staggered Accumulation as Peak Macro Concerns Subside Mercks Phase 3 TroFuse005 Trial for Endometrial Cancer Meets Dual Primary Endpoints Fed Dissenters Explain No Votes Over Signaling Next Move Could Be a Cut Health Care Stock Outlook Whats Next for Biotech Stocks California Water Service Group Director Disposes of 48400 in Company Shares Kazatomprom Reports 17 Production Increase in Third Quarter Underlining Uranium Supply Growth Fed Dissenters Voice Opposition to Signaling Rate Cut Cite Uncertainty